Financial Synergies Wealth Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Financial Synergies Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$130.4 - $143.74 $391 - $431	-3 Reduced 25.0%	9 $1.24 Million
Q4 2023 Apr 04, 2024	BUY	$106.07 - $132.76 $1,272 - $1,593	12 New	12 $1.43 Million
Q1 2023 Apr 04, 2024	SELL	$94.11 - $123.02 $1,129 - $1,476	-12 Closed	0 $0
Q3 2022 Apr 04, 2024	BUY	$92.03 - $107.81 $1,104 - $1,293	12 New	12 $1.28 Million

635

94.8M

472K

245K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.